The Latest: Pfizer seeks vaccine regulatory review in days
|
November 18, 2020 5:06 AM
NEW YORK — Pfizer announced more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
